Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

Clinical trial NCT04668521 · TERMINATED

Trial details

NCT number: NCT04668521
Sponsor: Aspira Women's Health
Status: TERMINATED
Study type: OBSERVATIONAL

Adnexal Mass Germline BRCA1 Gene Mutation Germline BRCA2 Gene Mutation Hereditary Breast and Ovarian Cancer

Start date: 2020-05-04
Primary completion: 2023-12-15
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.